Mixed drug intoxication involving zaleplon ("Sonata®")

Forensic Science International

Volumn 134, Issue 2-3, 2003, Pages 120-122

  Moore, Karla A ^a   Zemrus, Tasha L ^a   Ramcharitar, Vera ^a   Levine, Barry ^a   Fowler, David R ^a  

^a OFFICE OF THE CHIEF MEDICAL EXAMINER   (United States)

Author keywords

Drug overdose; Fatality; Forensic science; Suicide; Zaleplon

Indexed keywords

ZALEPLON;

ARTICLE; BILE COMPOSITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG INTOXICATION; FEMALE; HEART BLOOD VESSEL; HUMAN; HUMAN TISSUE; LETHAL DOSE; MULTIPLE DRUG DOSE; PRIORITY JOURNAL; SUICIDE; URINE LEVEL;

EID: 0037678664     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(03)00130-0     Document Type: Article

References (4)

1. Drover D., Lemmens H., Naidu S., Cevallos W., Darwish M., Stanski D. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. Clin. Ther. 22:2000;1443-1461.
2. Rosen A.S., Fournie P., Darwish M., Danjou P., Troy S.M. Zaleplon pharmacokinetics and absolute bioavailability. Biopharm. Drug Dispos. 20:1999;171-175.
3. Greenblatt D.J., Harmatz J.S., von Moltke L.L., Ehrenberg B.L., Harrel L., Corbett K., Counihan M., Graf J.A., Darwish M., Mertzanis P., Martin P.T., Cevallos W.H., Shader R.I. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin. Pharmacol. Ther. 64:1998;553-561.
4. Dooley M., Plosker G.L. Zaleplon: a review of its use in the treatment of insomnia. Drugs. 60:2000;413-445.